• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 228.91 (1)
Ask (Size) 228.96 (22)
Prev. Close 228.74
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 181,934,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Steal-of-a-Deal Stocks to Snap Up Right Now
February 26, 2024
Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now. 
Via InvestorPlace
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several... 
Via Benzinga
Topics Intellectual Property

Performance

More News

Read More
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
Via InvestorPlace
7 Dividend Stocks to Buy at a 52-Week Low
February 12, 2024
Via InvestorPlace
Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market
February 01, 2024
Via InvestorPlace
Looking Into Seagen's Recent Short Interest
December 13, 2023
Via Benzinga
Seagen Inc. (NASDAQ: SGEN) is a Leading Gainer in 12/12 Morning Trading
December 12, 2023
Via Investor Brand Network
What the Options Market Tells Us About Seagen
December 11, 2023
Via Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
Via InvestorPlace
How To Earn $500 A Month From Pfizer Stock
January 02, 2024
Via Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
Via Benzinga
3 Stocks That Are About to Get Absolutely Crushed
December 14, 2023
Via InvestorPlace
$100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
December 07, 2023
Via Benzinga
Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast
December 14, 2023
Via Benzinga
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
December 14, 2023
Via The Motley Fool
3 Sleepy Stocks Ready to Wake up in 2024
December 13, 2023
Via InvestorPlace
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
December 13, 2023
Via Benzinga
Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints
December 13, 2023
Via Investor's Business Daily
Why Is US Pharma Giant Pfizer Stock Trading Lower Today?
December 13, 2023
Via Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
December 12, 2023
Via Benzinga
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
Via Benzinga
ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma
December 10, 2023
From Seagen Inc.
Via Business Wire
3 Blue-Chip Stocks Set to Make a Comeback in 2024
December 08, 2023
Via InvestorPlace
TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
December 06, 2023
From Seagen Inc.
Via Business Wire
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023
Via Talk Markets

Frequently Asked Questions

Is Seagen Inc. - Common Stock publicly traded?
Yes, Seagen Inc. - Common Stock is publicly traded.
What exchange does Seagen Inc. - Common Stock trade on?
Seagen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Seagen Inc. - Common Stock?
The ticker symbol for Seagen Inc. - Common Stock is SGEN on the Nasdaq Stock Market
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap